Nucleic acid binding, RNA binding
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 19 | 
| NetGPI | no | yes: 0, no: 19 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0020022 | acidocalcisome | 5 | 1 | 
| GO:0043226 | organelle | 2 | 1 | 
| GO:0043227 | membrane-bounded organelle | 3 | 1 | 
| GO:0043229 | intracellular organelle | 3 | 1 | 
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 | 
| GO:0110165 | cellular anatomical entity | 1 | 2 | 
| GO:0016020 | membrane | 2 | 1 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| 
                        
                            Lahav et al. - mRNA 
                            - Protein 
                        
                     | 
                    
Related structures:
AlphaFold database: A4HY39
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005488 | binding | 1 | 14 | 
| GO:0043167 | ion binding | 2 | 13 | 
| GO:0043169 | cation binding | 3 | 13 | 
| GO:0046872 | metal ion binding | 4 | 13 | 
| GO:0003824 | catalytic activity | 1 | 1 | 
| GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 | 
| GO:0016740 | transferase activity | 2 | 1 | 
| GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 | 
| GO:0140096 | catalytic activity, acting on a protein | 2 | 1 | 
| GO:0003676 | nucleic acid binding | 3 | 1 | 
| GO:0003723 | RNA binding | 4 | 1 | 
| GO:0097159 | organic cyclic compound binding | 2 | 1 | 
| GO:1901363 | heterocyclic compound binding | 2 | 1 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.433 | 
| CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.476 | 
| CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.525 | 
| CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.538 | 
| CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.374 | 
| CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.502 | 
| CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.468 | 
| CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.478 | 
| CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.681 | 
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.593 | 
| DOC_CYCLIN_RxL_1 | 37 | 47 | PF00134 | 0.326 | 
| DOC_MAPK_MEF2A_6 | 210 | 219 | PF00069 | 0.478 | 
| DOC_MAPK_MEF2A_6 | 244 | 253 | PF00069 | 0.397 | 
| DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.327 | 
| DOC_MAPK_NFAT4_5 | 39 | 47 | PF00069 | 0.326 | 
| DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.638 | 
| DOC_USP7_MATH_1 | 332 | 336 | PF00917 | 0.629 | 
| DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.614 | 
| DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.522 | 
| DOC_USP7_UBL2_3 | 367 | 371 | PF12436 | 0.598 | 
| DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.496 | 
| DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.508 | 
| LIG_14-3-3_CanoR_1 | 282 | 292 | PF00244 | 0.473 | 
| LIG_14-3-3_CanoR_1 | 39 | 43 | PF00244 | 0.544 | 
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.542 | 
| LIG_FHA_1 | 22 | 28 | PF00498 | 0.456 | 
| LIG_FHA_2 | 127 | 133 | PF00498 | 0.389 | 
| LIG_FHA_2 | 284 | 290 | PF00498 | 0.521 | 
| LIG_GBD_Chelix_1 | 44 | 52 | PF00786 | 0.390 | 
| LIG_LIR_Gen_1 | 57 | 64 | PF02991 | 0.499 | 
| LIG_LIR_Nem_3 | 262 | 268 | PF02991 | 0.347 | 
| LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.500 | 
| LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.504 | 
| LIG_LRP6_Inhibitor_1 | 272 | 278 | PF00058 | 0.339 | 
| LIG_NRBOX | 145 | 151 | PF00104 | 0.460 | 
| LIG_PTB_Apo_2 | 264 | 271 | PF02174 | 0.354 | 
| LIG_PTB_Phospho_1 | 264 | 270 | PF10480 | 0.373 | 
| LIG_SH2_CRK | 234 | 238 | PF00017 | 0.476 | 
| LIG_SH2_CRK | 59 | 63 | PF00017 | 0.395 | 
| LIG_SH2_CRK | 70 | 74 | PF00017 | 0.373 | 
| LIG_SH2_GRB2like | 299 | 302 | PF00017 | 0.486 | 
| LIG_SH2_SRC | 90 | 93 | PF00017 | 0.474 | 
| LIG_SH2_STAP1 | 270 | 274 | PF00017 | 0.359 | 
| LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.387 | 
| LIG_SH2_STAT3 | 125 | 128 | PF00017 | 0.489 | 
| LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.473 | 
| LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.371 | 
| LIG_SH3_3 | 153 | 159 | PF00018 | 0.626 | 
| LIG_SH3_3 | 171 | 177 | PF00018 | 0.443 | 
| LIG_SH3_3 | 291 | 297 | PF00018 | 0.538 | 
| LIG_SH3_3 | 90 | 96 | PF00018 | 0.346 | 
| LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.411 | 
| MOD_CK1_1 | 126 | 132 | PF00069 | 0.444 | 
| MOD_CK1_1 | 315 | 321 | PF00069 | 0.554 | 
| MOD_CK1_1 | 345 | 351 | PF00069 | 0.738 | 
| MOD_CK1_1 | 372 | 378 | PF00069 | 0.617 | 
| MOD_CK2_1 | 126 | 132 | PF00069 | 0.387 | 
| MOD_CK2_1 | 283 | 289 | PF00069 | 0.520 | 
| MOD_CK2_1 | 352 | 358 | PF00069 | 0.684 | 
| MOD_CK2_1 | 44 | 50 | PF00069 | 0.425 | 
| MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.607 | 
| MOD_GlcNHglycan | 227 | 231 | PF01048 | 0.579 | 
| MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.587 | 
| MOD_GlcNHglycan | 347 | 350 | PF01048 | 0.639 | 
| MOD_GlcNHglycan | 379 | 382 | PF01048 | 0.703 | 
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.452 | 
| MOD_GSK3_1 | 119 | 126 | PF00069 | 0.457 | 
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.437 | 
| MOD_GSK3_1 | 23 | 30 | PF00069 | 0.543 | 
| MOD_GSK3_1 | 97 | 104 | PF00069 | 0.387 | 
| MOD_N-GLC_1 | 139 | 144 | PF02516 | 0.381 | 
| MOD_N-GLC_1 | 332 | 337 | PF02516 | 0.666 | 
| MOD_NEK2_1 | 27 | 32 | PF00069 | 0.468 | 
| MOD_NEK2_1 | 283 | 288 | PF00069 | 0.524 | 
| MOD_NEK2_1 | 44 | 49 | PF00069 | 0.389 | 
| MOD_OFUCOSY | 281 | 287 | PF10250 | 0.509 | 
| MOD_PIKK_1 | 123 | 129 | PF00454 | 0.358 | 
| MOD_PIKK_1 | 21 | 27 | PF00454 | 0.522 | 
| MOD_PIKK_1 | 332 | 338 | PF00454 | 0.513 | 
| MOD_PKA_2 | 345 | 351 | PF00069 | 0.543 | 
| MOD_PKA_2 | 38 | 44 | PF00069 | 0.541 | 
| MOD_Plk_1 | 108 | 114 | PF00069 | 0.475 | 
| MOD_Plk_1 | 139 | 145 | PF00069 | 0.401 | 
| MOD_Plk_1 | 261 | 267 | PF00069 | 0.372 | 
| MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.375 | 
| MOD_Plk_4 | 27 | 33 | PF00069 | 0.549 | 
| MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.490 | 
| MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.509 | 
| MOD_SUMO_for_1 | 389 | 392 | PF00179 | 0.645 | 
| MOD_SUMO_rev_2 | 111 | 120 | PF00179 | 0.485 | 
| MOD_SUMO_rev_2 | 75 | 80 | PF00179 | 0.503 | 
| TRG_DiLeu_BaLyEn_6 | 162 | 167 | PF01217 | 0.414 | 
| TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.361 | 
| TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.369 | 
| TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.380 | 
| TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.422 | 
| TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.495 | 
| TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.527 | 
| TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.515 | 
| TRG_ER_diLys_1 | 388 | 392 | PF00400 | 0.670 | 
| TRG_NES_CRM1_1 | 148 | 160 | PF08389 | 0.589 | 
| TRG_NES_CRM1_1 | 37 | 50 | PF08389 | 0.513 | 
| TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.451 | 
| TRG_Pf-PMV_PEXEL_1 | 144 | 148 | PF00026 | 0.388 | 
| TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.422 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I1I4 | Leptomonas seymouri | 70% | 99% | 
| A0A0N1PG85 | Leptomonas seymouri | 32% | 100% | 
| A0A0S4KEK3 | Bodo saltans | 37% | 100% | 
| A0A1X0P6E1 | Trypanosomatidae | 36% | 100% | 
| A0A3Q8IA61 | Leishmania donovani | 31% | 100% | 
| A0A3R7RSV6 | Trypanosoma rangeli | 34% | 100% | 
| A0A3S7WVD2 | Leishmania donovani | 99% | 100% | 
| A0A422P3A2 | Trypanosoma rangeli | 40% | 96% | 
| A4H9Y7 | Leishmania braziliensis | 32% | 100% | 
| A4H9Y8 | Leishmania braziliensis | 74% | 100% | 
| A4HY52 | Leishmania infantum | 31% | 100% | 
| D0A0F3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% | 
| D0A0F7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 91% | 
| E9ARY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 99% | 
| E9ARY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% | 
| Q4QDJ1 | Leishmania major | 30% | 99% | 
| V5BSB1 | Trypanosoma cruzi | 37% | 82% | 
| V5BWY8 | Trypanosoma cruzi | 33% | 100% |